Links to other pages within Patient UK which are related to this topic:
Experience | Patient+ | Guidelines | News | Products | Other
Print options:   Other options:   (what's this?)

This is a PatientPlus article. PatientPlus articles are written for doctors and so the language can be technical. However, some people find that they add depth to the articles found in the other sections of this website which are written for non-medical people.

Stevens-Johnson Syndrome

Stevens-Johnson syndrome is an immune-complex-mediated hypersensitivity complex. It ranges from mild skin and mucous membrane lesions to a severe, sometimes fatal systemic disorder. Ocular symptoms include ulcerative conjunctivitis, keratitis, iritis, uveitis, and sometimes blindness.

It is considered by some as being part of a spectrum of disease which includes, in order of severity, erythema multiforme, Stevens-Johnson syndrome (SJS) and Toxic Epidermal Necrolysis (TEN). However, others argue that as erythema multiforme is associated with infections including herpes simplex virus and Mycoplasma pneumoniae, whereas SJS and TEN are necrolytic bullous reactions to certain drugs, erythema multiforme should not be classified as part of the same disease spectrum.1

Another classification system works on the fact that SJS and TEN are related conditions that can be differentiated by the degree of skin involvement. Less than 10% of the epidermis sloughs off in Stevens-Johnson syndrome as compared to >30% in TEN.2

Epidemiology
  • Incidence is estimated at 2-3 cases/million population/year in Europe.3
  • More common in Caucasians.
  • More common in females than males.3
  • Most patients are aged 10-30 but cases have been reported in children as young as 3 months.
  • Tends to be more common in winter and early spring.

Risk factors

  • Past history of Stevens-Johnson syndrome or erythema multiforme.
  • Recurrences may occur if the responsible agent is not eliminated or if there is a further exposure (e.g. drug).
Causes

The most common causes in adults are drugs and malignancies. In children, the most common causes are infections.

Presentation

Images available via internet.6,7

  • Typically involves the skin and the mucous membranes.
  • Minor presentations may occur but presentation may be severe with significant involvement of mouth, nose, eye, vagina, urethra, gastrointestinal tract and lower respiratory tract mucous membranes.
  • Lesions may continue to erupt in crops for as long as 2-3 weeks.

Symptoms

  • Often starts with a non-specific upper respiratory tract infection, which may be associated with fever, sore throat, chills, headache, arthralgia, vomiting and diarrhoea, and malaise.
  • Mucocutaneous lesions develop suddenly and clusters of outbreaks last from 2-4 weeks. The lesions are usually not pruritic.
  • Mouth involvement may be severe enough that patients may not be able to eat or drink.
  • Respiratory involvement may cause a cough productive of a thick purulent sputum.
  • Patients with genitourinary involvement may complain of dysuria or an inability to pass urine.

Signs

  • General examination: fever, tachycardia, hypotension. Altered level of consciousness, seizures, coma.
  • Skin:
    • Lesions may occur anywhere, but most commonly affect the palms, soles, dorsum of hands and extensor surfaces. The rash may be confined to any one area of the body, most often the trunk.
    • The rash can begin as macules that develop into papules, vesicles, bullae, urticarial plaques, or confluent erythema.
    • The center of the lesions may be vesicular, purpuric, or necrotic.
    • The typical lesion has the appearance of a target, which is considered pathognomonic.
    • Lesions may become bullous and later rupture. The skin becomes susceptible to secondary infection.
    • Urticarial lesions are usually not pruritic.
  • Mucosal involvement: erythema, oedema, sloughing, blistering, ulceration and necrosis.
  • Eye: conjunctivitis, corneal ulcerations.
  • Genital: erosive vulvovaginitis or balanitis.
Differential diagnosis
Investigations
  • There are no specific investigations.
  • Skin biopsy: demonstrates that the bullae are subepidermal. Epidermal cell necrosis may be seen and perivascular areas are infiltrated with lymphocytes.
Associated diseases
  • Stevens-Johnson syndrome and toxic epidermal necrolysis are variations of the same disease.
  • Toxic epidermal necrosis has a higher mortality (30-35%).8 Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis are differentiated by the extent of epidermal detachment, with greater detachment occurring in toxic epidermal necrolysis.9
Management
  • Treatment is supportive:
    • Attention to airway and haemodynamic stability.
    • Severe fluid loss may require intravenous fluid replacement and electrolyte correction.
    • Pain control.
    • Skin lesions are treated in the same way as for burns.
    • Mouth: mouthwashes; topical anaesthetics are useful in reducing pain and allowing the patient to take in fluids.
  • Management of underlying cause, including identifying and stopping any drug cause.
  • Treatment of secondary infection.
  • Some have advocated cyclophosphamide, plasmapheresis, haemodialysis and immunoglobin therapy, but none of those should be considered standard at this time.8
  • The use of systemic steroids is controversial. Some authors believe that they are contraindicated. Treatment with systemic steroids has been associated with an increased prevalence of complications.8
  • Early administration of high-dose intravenous immunoglobulin helps to resolve SJS and reduce mortality. Immunoglobulin treatment is recommended in patients with contraindications to corticosteroid or immunosuppressive therapy.10
Complications
  • Gastrointestinal and respiratory involvement may progress to necrosis.
  • Skin: secondary infection and scarring.
  • Mucosal pseudomembrane formation may lead to mucosal scarring and loss of function of the involved organ system.
  • Extensive involvement of the oesophagus may cause oesophageal strictures.
  • Lung: mucosal shedding in the tracheobronchial tree may lead to respiratory failure.
  • Eye complications: include corneal ulceration and anterior uveitis. Blindness may develop secondary to severe keratitis or panophthalmitis in 3-10% of patients.
  • Vaginal stenosis and penile scarring have been reported.
  • Renal complications are uncommon but renal tubular necrosis and renal failure may occur.
Prognosis
  • Individual lesions usually heal within 1-2 weeks, unless secondary infection occurs.
  • Most patients make a full recovery.
  • The prognosis depends on the development of associated serious complications.
  • The mortality rate has been reported to be 1-3%.11
Prevention
  • Future avoidance of any possible or confirmed underlying cause.


Document references
  1. Becker DS; Toxic epidermal necrolysis. Lancet. 1998 May 9;351(9113):1417-20.
  2. Freiman A, Borsuk D, Sasseville D; Dermatologic emergencies.CMAJ November 22, 2005; 173 (11).
  3. Fritsch P; European Dermatology Forum: skin diseases in Europe. Skin diseases with a high public health impact: toxic epidermal necrolysis and Stevens-Johnson syndrome. Eur J Dermatol. 2008 Mar-Apr;18(2):216-7.
  4. Leaute-Labreze C, Lamireau T, Chawki D, et al; Diagnosis, classification, and management of erythema multiforme and Stevens-Johnson syndrome. Arch Dis Child. 2000 Oct;83(4):347-52. [abstract]
  5. Fritsch PO, Sidoroff A; Drug-induced Stevens-Johnson syndrome/toxic epidermal necrolysis. Am J Clin Dermatol. 2000 Nov-Dec;1(6):349-60. [abstract]
  6. DermNet NZ; Stevens-Johnson syndrome
  7. Dermatology Image Atlas; Target Lesions
  8. Ghislain PD, Roujeau JC; Treatment of severe drug reactions: Stevens-Johnson syndrome, toxic epidermal necrolysis and hypersensitivity syndrome. Dermatol Online J. 2002 Jun;8(1):5. [abstract]
  9. Bastuji-Garin S, Rzany B, Stern RS, et al; Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol. 1993 Jan;129(1):92-6. [abstract]
  10. Clinical guidelines for the use of intravenous immunoglobulin, Department of Health (November 2007)
  11. Foster CS; Stevens-Johnson Syndrome.; eMedicine, December 2007.

Internet and further reading Acknowledgements EMIS is grateful to Dr Colin Tidy for writing this article. The final copy has passed scrutiny by the independent Mentor GP reviewing team. ©EMIS 2009.
Document ID: 2801
Document Version: 23
Document Reference: bgp1287
Last Updated: 2 Jun 2009
Planned Review: 2 Jun 2011

The authors and editors of this article are employed to create accurate and up to date content reflecting reliable research evidence, guidance and best clinical practice. They are free from any commercial conflicts of interest.

Find out more about updating.

(what's this?)

Patient UK Current Health News

Advertisements











Disclaimer: Patient UK has no control over the content of any external links above. Inclusion does not imply endorsement by Patient UK.

Want to advertise on this site? Find out how >>

Clicking here will take you to the foot of this page where you'll find a list of Information Leaflets which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of Support Groups which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of Medicines & Drugs which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of diagrams which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of PatientPlus (detailed reference) articles which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of UK Guidelines which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of other selected websites which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of Poems and Stories which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of Operations and Procedures which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find a list of Online Videos which are related to the topic you are currently viewing
Clicking here will take you to the foot of this page where you'll find links through to our interactive forum.
Here you can follow a link to view existing patient experiences on this subject, or to add your own
Clicking here will take you to the foot of this page where you'll find links to news stories on this subject in our Online Newspaper
Clicking here will take you to the foot of this page where you'll find links to related products
Clicking here will take you to the foot of this page where you'll find links to other useful sources of information
Click here to open a printer-friendly version of this document, in a new window, together with the print dialogue box
Click here to open this document in PDF format
This will offer you the usual PDF options i.e. document navigation, search, zoom and formatted print
Note: this is the best way to print the document
Click here to listen to the MP3 audio recording of this document
Click here to download the audio recording of this document as a podcast, for listening to at your leisure
Click here to open our Dictionaries and Glossaries page
Click here to see related products in our Online Pharmacy
Note: this will open in a new window
Click here to add this page to a social bookmarking site of your choice
Click here if you want to find out more about social bookmarking. This link will take you to the Wikipedia explanation
Note: this will open in a new window
Click here to return to the home page
Click here to read our 'About Us' page
Go to the Emis Access website, where you can book an appointment with your GP, order a repeat prescription or view you medical record online.
Note: this will open in a new window
View and/or join in discussion about health, lifestyle and disease in our interactive forum.
Note: this will open in a new window
Go to our online pharmacy where you can buy over-the-counter products for home delivery.
Note: this will open in a new window
Go to our online newspaper for current medical news and commentary.
Note: this will open in a new window
Adverts on this site do not influence the medical content. Click to read more.
Adverts on this site do not influence the medical content. Click to read more.